Literature DB >> 33914899

Aerobic reserve capacity in multiple sclerosis-Preliminary evidence.

Corey D Feasel1, Brian M Sandroff1,2, Robert W Motl1.   

Abstract

OBJECTIVES: Aerobic reserve capacity reflects the available energy for performing everyday life tasks, and it has been studied in older adult populations. This preliminary study examined proof of concept and measurement of aerobic reserve capacity in multiple sclerosis (MS). MATERIALS &
METHODS: Twenty-one fully ambulatory people with MS performed a maximal, cardiopulmonary exercise test (CPET). We calculated aerobic reserve capacity based on the difference between peak aerobic power (VO2peak ) and first stage oxygen consumption (VO2 ). Participants completed assessments for disability (Expanded Disability Status Scale, EDSS), cognition (Symbol Digit Modalities Test, SDMT), mood (Beck Depression Inventory, BDI), walking endurance (six-minute walk distance, 6MWD), walking speed (Timed Twenty-Foot Walk, T25FW), impact of MS (Multiple Sclerosis Impact Scale, MSIS-29), and anthropometric measurements (height and weight).
RESULTS: Aerobic reserve capacity was 9.3 ± 3.7 ml/kg/min. Aerobic reserve capacity was positively associated with VO2peak (ρ = .67, p < .01), time to exhaustion (ρ = .63, p < .01), and SDMT (ρ = .51, p < .05). Aerobic reserve capacity was negatively associated with BMI (ρ = -.62, p < .01) and RHR (ρ = -0.47, p < .05).
CONCLUSION: We provide preliminary evidence that aerobic reserve capacity is a feasible outcome derived from maximal CPET (eg, modified Balke protocol) in MS. Aerobic reserve capacity was associated with clinically relevant outcomes and could become an important outcome for rehabilitation in future research.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  aerobic power; aerobic reserve capacity; energetic cost of walking; multiple sclerosis; rehabilitation

Mesh:

Year:  2021        PMID: 33914899      PMCID: PMC9270568          DOI: 10.1111/ane.13441

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.915


  23 in total

Review 1.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

2.  Depression in multiple sclerosis: The utility of common self-report instruments and development of a disease-specific measure.

Authors:  Lauren B Strober; Peter A Arnett
Journal:  J Clin Exp Neuropsychol       Date:  2015-07-30       Impact factor: 2.475

3.  Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.

Authors:  Myla D Goldman; Ruth Ann Marrie; Jeffrey A Cohen
Journal:  Mult Scler       Date:  2007-10-17       Impact factor: 6.312

4.  Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale.

Authors:  Gail L Widener; Diane D Allen
Journal:  Arch Phys Med Rehabil       Date:  2014-03       Impact factor: 3.966

5.  Aerobic reserve and physical functional performance in older adults.

Authors:  Scott W Arnett; Jennifer H Laity; Subodh K Agrawal; M Elaine Cress
Journal:  Age Ageing       Date:  2008-02-20       Impact factor: 10.668

6.  Systematically developed pilot randomized controlled trial of exercise and cognition in persons with multiple sclerosis.

Authors:  Brian M Sandroff; Julia M Balto; Rachel E Klaren; Sarah K Sommer; John DeLuca; Robert W Motl
Journal:  Neurocase       Date:  2016-09-27       Impact factor: 0.881

7.  Energy cost of walking and exertional dyspnea in multiple sclerosis.

Authors:  R Olgiati; J Jacquet; P E Di Prampero
Journal:  Am Rev Respir Dis       Date:  1986-11

8.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

9.  Aerobic Fitness and Instrumental Activities of Daily Living in People with Multiple Sclerosis: A Cross-sectional Study.

Authors:  Emerson Sebastião; Lara A Pilutti; Robert W Motl
Journal:  Int J MS Care       Date:  2019 Jan-Feb

10.  Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.

Authors:  Ralph Hb Benedict; John DeLuca; Glenn Phillips; Nicholas LaRocca; Lynn D Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.